The Role of the Pregnane X Receptor (PXR) in Indole Signaling and Intestinal Permeability in Inflammatory Bowel Disease
NCT04089501 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 43
Last updated 2019-09-16
Summary
The goal of this study is to better understand the mechanisms responsible for the development of and the severity of Inflammatory Bowel Disease (IBD), such as Crohn's Disease and Ulcerative Colitis, which cause inflammation of the gut as well as potentially affecting other areas of the body
Conditions
- Inflammatory Bowel Diseases
Interventions
- DIAGNOSTIC_TEST
-
Stool collection
Stool will be collected from subjects who have been diagnosed with IBD or whom small intestinal, colonic or ileocolonic and have signed consent for the control group. Stool will be self-collected or through routine colonoscopy procedure.
- DIAGNOSTIC_TEST
-
Biopsy collection
3 additional biopsies (for research purposes) will be taken from patients who undergo colonoscopy as per standard of care
Sponsors & Collaborators
-
National Cancer Institute (NCI)
collaborator NIH -
Albert Einstein College of Medicine
lead OTHER
Principal Investigators
-
Sridhar Mani, MD · Albert Einstein College of Medicine
Eligibility
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-02-25
- Primary Completion
- 2019-05-02
- Completion
- 2019-05-02
Countries
- United States
Study Locations
More Related Trials
-
A Study to Evaluate the Safety of PRV-300 in Adult Subjects With Moderately to Severely Active Ulcerative Colitis
NCT03849599 ·Status: COMPLETED ·Phase: PHASE1
-
Blood and Stool Molecular Biomarkers Longitudinal Detection Study in Crohn's Disease (CD) Patients
NCT03566407 ·Status: TERMINATED ·Phase: NA
-
Safety and Activity Study of an Oral Medication to Treat Moderate to Severe Crohn's Disease
NCT00102921 ·Status: COMPLETED ·Phase: PHASE2
-
Study of an Environmental Risk Factor in Crohn's Disease
NCT04960826 ·Status: RECRUITING
-
Biomarkers of Intestinal Mucosal Healing in Crohn's Disease (P08143)
NCT01349920 ·Status: COMPLETED
-
Immune Regulation in Ulcerative Colitis or Crohn s Disease
NCT00001184 ·Status: RECRUITING
-
Anorectal Function in Perianal Crohn's Disease
NCT03819257 ·Status: COMPLETED
-
A Phase 2a Study to Evaluate the Safety, Tolerability, Pharmacodynamics and Efficacy of AG011 in Ulcerative Colitis
NCT00729872 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Study of MDX-1100 in Subjects With Active Ulcerative Colitis
NCT00656890 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of the Diagnostic Value of microRNAs for Inflammatory Bowel Diseases
NCT02020382 ·Status: COMPLETED ·Phase: NA
-
PET/CT to Predict Response to Infliximab Therapy in Patients With Crohn's Disease
NCT01759017 ·Status: TERMINATED
-
Genomic/Epigenomic Biomarkers of Deregulation of Immune System in Inflammatory Bowel Diseases
NCT02878395 ·Status: UNKNOWN
-
Immunological Characteristics of Preclinical IBD
NCT05698745 ·Status: RECRUITING
-
Therapeutic Modulation of the Intestinal Creatine Kinase System in Inflammatory Bowel Disease (IBD)
NCT02463305 ·Status: WITHDRAWN ·Phase: EARLY_PHASE1
-
Chromoendoscopy for Ulcerative Colitis Surveillance
NCT00274209 ·Status: COMPLETED
-
Investigation of the Correlation Between Polyamine Levels and Their Key Enzymatic Activities in Association With Inflammatory Bowel Disease Progression
NCT06995170 ·Status: RECRUITING
-
Mucosal Innate Immune Activation in Chronic Intestinal Disorders
NCT03529318 ·Status: WITHDRAWN
-
Investigation of Sexual Function in Crohn's Disease Patients With Perianal Fistulas
NCT01635543 ·Status: WITHDRAWN
-
Safety and Efficacy Trial of RPC1063 for Moderate to Severe Ulcerative Colitis
NCT02435992 ·Status: COMPLETED ·Phase: PHASE3
-
Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis
NCT06619990 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Study to Evaluate Safety, Tolerability and Efficacy of Oral E-B-FAHF-2 in Mild-to-Moderate Crohn's Disease
NCT03992469 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Cytokines and Genes in Therapeutic Response in Crohn's Disease
NCT03266471 ·Status: COMPLETED
-
Endocytoscopy for in Vivo Determination of Mucosal Inflammatory Cells and Intestinal Disease Activity in Inflammatory Bowel Disease (IBD)
NCT01289366 ·Status: COMPLETED
-
Safety and Efficacy of Natalizumab in the Treatment of Crohn's Disease
NCT00032799 ·Status: COMPLETED ·Phase: PHASE3
-
Magnification Endoscopy and Electronic Chromoendoscopy in Patients With Inflammatory Bowel Disease
NCT03536091 ·Status: COMPLETED